87% Survival – New Combined Therapy Greatly Improves Prostate Cancer Survival

France Nouvelles Nouvelles

87% Survival – New Combined Therapy Greatly Improves Prostate Cancer Survival
France Dernières Nouvelles,France Actualités
  • 📰 SciTechDaily1
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 68%

A Cedars-Sinai cancer study indicates improved survival following a combination of hormone therapy and pelvic lymph node treatment A combination of androgen deprivation therapy—a common hormone injection—and pelvic lymph node radiotherapy prevented prostate cancer from therapy in nearly 90% of clin

The combination therapy patient group underwent pelvic lymph node radiation and androgen deprivation treatment, as well as salvage prostate bed radiation. Over 87 percent of these patients had five-year freedom from cancer progression.

The research also demonstrates that individuals with prostate cancer who did not get pelvic lymph node radiotherapy or androgen restriction treatment had a five-year survival rate of 70%. Salvage prostate bed radiotherapy was administered to Group 1; this kind of radiation is often directed towards the prostate’s former location before it was surgically removed. The median five-year survival rate for these individuals was 71%.

“The combined treatment approach proved to be the most beneficial approach,” said Sandler, also the Ronald H. Bloom Family Chair in Cancer Therapeutics and professor of Radiation Oncology at Cedars-Sinai.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

SciTechDaily1 /  🏆 84. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Missing vulnerable 87-year-old man foundMissing vulnerable 87-year-old man foundTucson police is in search of a missing vulnerable 87-year-old man. The man is identified as Jose Yescas.
Lire la suite »

Missing vulnerable 87-year-old manMissing vulnerable 87-year-old manTucson police is in search of a missing vulnerable 87-year-old man. The man is identified as Jose Yescas.
Lire la suite »

Where The Crawdads Sing Begins and Ends With SurvivalWhere The Crawdads Sing Begins and Ends With SurvivalThe film, based off the bestselling novel, offers a meditation on abuse and trauma
Lire la suite »

How climate change is now threatening the survival of fire-adaptive sequoia treesHow climate change is now threatening the survival of fire-adaptive sequoia treesNestled on the Western slope of the Sierra Nevada mountain range live isolated patches of some of the world's oldest and most magnificent species of tree.
Lire la suite »

My Last Visit with John BennetMy Last Visit with John Bennet.MaryNorrisTNY remembers her final visits with the former New Yorker editor John Bennet, who died earlier this month.
Lire la suite »

Amazon Involved With New Cancer Vaccine Clinical TrialAmazon Involved With New Cancer Vaccine Clinical TrialAmazon is working with the Fred Hutchinson Cancer Research Center to develop cancer vaccines in a new clinical trial.
Lire la suite »



Render Time: 2025-03-13 19:23:20